(Q35992076)

11 August 2017

Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker (English)

1 reference

https://api.crossref.org/works/10.1038/BJC.1984.254

11 August 2017

1 reference

1 reference

29 August 2023

author name string

P. A. Canney

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6208925

29 August 2023

M. Moore

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6208925

29 August 2023

P. M. Wilkinson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6208925

29 August 2023

R. D. James

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6208925

29 August 2023

language of work or name

English

0 references

publication date

1 December 1984

1 reference

full work available at URL

11 August 2017

https://europepmc.org/articles/PMC1977011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6208925

https://europepmc.org/articles/PMC1977011?pdf=render

29 August 2023

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6208925

http://www.nature.com/articles/bjc1984254.pdf

29 August 2023

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/BJC.1984.254

http://www.nature.com/articles/bjc1984254

29 August 2023

1 reference

https://api.crossref.org/works/10.1038/BJC.1984.254

British Journal of Cancer

29 August 2023

published in

1 reference

11 August 2017

50

1 reference

11 August 2017

6

1 reference

11 August 2017

765-769

1 reference

Chemotherapy of advanced malignant teratomas

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977011

Reactivity of a monoclonal antibody with human ovarian carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977011

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977011

Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation).

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977011

Second-look operation in ovarian carcinoma: postchemotherapy

23 September 2018

1 reference

12 December 2020

Multiple biochemical markers in patients with gynecologic malignancies

1 reference

12 December 2020

Monoclonal antibodies recognizing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas

1 reference

12 December 2020

Abdomino-pelvic computed tomography in the management of ovarian carcinoma

1 reference

12 December 2020

Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens of human ovarian tumors of serous, endometrioid, and clear cell types

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1984.254

1 reference

Dimensions Publication ID

11 August 2017

0 references

1 reference

11 August 2017

1 reference